Sentences with phrase «breast cancer studies by»

Breast Cancer News and Reviews Here's where to find news about breast cancer research, and reviews of breast cancer studies by Dr. John Lee and Virginia Hopkins

Not exact matches

By Andrew M. Seaman NEW YORK (Reuters Health)- Factors other than medical history and risk may influence women with cancer in one breast to have both breasts removed even if it doesn't improve their odds of survival, suggests a new study.

According to a study published by Lund University Publications, the longer a woman breastfeeds, the less likely she is to develop breast cancer.

In fact, a study published by The Archives of Internal Medicine found that for women with an immediate family member who had breast cancer, those who breastfeed have a 59 % lower risk of developing breast cancer.

But a larger group of studies over the past ten years has proved that women who breastfeed their children past the age of two years actually reduce their chances of contracting pre-menopausal breast cancer by 30 percent.

After standardizing the data for age, menopausal status, and economic standing of her country (so that these factors did not influence the results), this study concluded that a woman who breastfed for 12 months in her life reduced her risk of developing breast cancer by 4.3 %.

A study of nearly 3,000 women conducted by researchers at the University of Buffalo in New York found women who experienced morning sickness during pregnancy were 30 percent less likely to have breast cancer later in life.

According to the recent study, which will be published next month in the print version of the American Journal of Clinical Nutrition, breastfeeding can cut the risk of breast cancer by up to 91 percent.

Rather than posting what color your bra is or where you «like it» why not post something informative like this study which shows that breastfeeding for at least 2 years lowers the typical woman's breast cancer risk by 50 %?

Or this study which shows that if you have a family history of breast cancer, breastfeeding for just 3 months can cut your chances of getting breast cancer by 50 % and be just as beneficial as taking breast cancer preventing medication for FIVE years?

One study indicates that breast cancer in the United States could decline by 25 % if all women would breastfeed their children for at least two years.

Aug. 10, 2009 — Women with a family history of breast cancer who have ever breastfed reduce their risk of getting premenopausal breast cancer by nearly 60 %, according to a new study.

Studies in which women who already have breast cancer are asked about their breastfeeding history can be flawed by «recall bias,» she says.

BREAST cancer screening in East Anglia has reduced deaths from the disease by nearly half, according to a study published in the British Journal of Cancer * today (Tuecancer screening in East Anglia has reduced deaths from the disease by nearly half, according to a study published in the British Journal of Cancer * today (TueCancer * today (Tuesday).

If supported by further studies, he believes that the monitoring should be carried out at regular intervals after the breast cancer surgery.

The study, led by Dr Len Stephens and Dr Phill Hawkins and published today in the journal Molecular Cell, reveals why loss of the PTEN gene has such an impact on many people with prostate cancer, as well as in some breast cancers.

«Nonetheless, the proof of concept studies we have obtained thus far are extremely encouraging, and we are confident that with proper support and efforts we could translate our findings into experimental therapeutics for a variety of solid tumors that are driven by EphA2 overexpression, including breast, lung, prostate, pancreatic, and ovarian cancers,» said Pellecchia, who serves as the founding director of the Center for Molecular and Translational Medicine at UCR.

An earlier study that didn't take parental influence into account found one variant on chromosome 11 raised the risk of breast cancer by 7 per cent.

But a major study by a Danish team, to be published this Saturday in The Lancet should help allay those fears: It found the risk of death among more than 5000 breast cancer survivors was no greater for those women who became pregnant.

Vitamin C has previously been shown to be effective as a non-toxic anti-cancer agent in studies by Nobel Prize winner Linus Pauling and was recently shown to reduce mortality by 25 % on breast cancer patients in Japan.

In the Cell study, Dr. Massagué, with Fellow Manuel Valiente, PhD, and other team members, found that in mouse models of breast and lung cancer — two tumor types that often spread to the brain — many cancer cells that enter the brain are killed by astrocytes.

The MINDACT study is managed and sponsored by the EORTC in collaboration with the Breast International Group (BIG) and included 6,693 women with early stage breast cancer (lymph node negative or 1 - 3 lymph node posiBreast International Group (BIG) and included 6,693 women with early stage breast cancer (lymph node negative or 1 - 3 lymph node posibreast cancer (lymph node negative or 1 - 3 lymph node positive).

The researchers at 30 radiotherapy centres across the UK, led by The Institute of Cancer Research, London, and the Cancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingCancer Research, London, and the Cancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingCancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingcancer that was at a low risk of coming back.

Surgical oncologists, or cancer surgeons, usually remove breast cancers by relying on tactile feedback and radiologic images of the tumor, such as mammograms and ultrasound images, said M. Catherine Lee, MD, FACS, coauthor of the first study and associate professor of surgery at H. Lee Moffitt Cancer Center, Tampa,cancer surgeons, usually remove breast cancers by relying on tactile feedback and radiologic images of the tumor, such as mammograms and ultrasound images, said M. Catherine Lee, MD, FACS, coauthor of the first study and associate professor of surgery at H. Lee Moffitt Cancer Center, Tampa,Cancer Center, Tampa, Fla..

The study, «AKR1B1 promotes basal - like breast cancer progression by a positive feedback loop that activates the EMT program,» which has been published in The Journal of Experimental Medicine, suggests that an inhibitor of this enzyme currently used to treat diabetes patients could be an effective therapy for this frequently deadly form of cancer.

Extensive studies have found that 20 % to 30 % of breast cancers are characterized by over-expression of HER2, which makes the cancer cells grow and divide faster, leading to a cancer that's more aggressive and more likely to be resistant to the standard of care.

These carriers were found to have only a 56 % chance of developing breast cancer by age 70, compared with a figure of 87 % in previous studies.

Another study, conducted by Barbara Weber and her colleagues at the University of Pennsylvania, screened 263 breast cancer patients for BRCA1 mutations and asked them about their family history of breast and ovarian cancers.

Stamets furnished capsules of freeze - dried fungus for a seven - year, NIH - funded study by Bastyr University and the University of Minnesota to determine whether turkey tail mushrooms could help breast cancer patients whose immune systems had been compromised by radiation therapy.

«Obesity is a well - established risk factor for breast cancer in the general population and some studies suggest that maintaining a healthy lifestyle by exercising or avoiding obesity may decrease the likelihood of developing cancer in BRCA mutation carriers.»

To see whether cancer stem cell renewal involves a chain of events similar to that used by embryonic stem cells, and whether the process was affected by oxygen levels, Semenza and graduate student Chuanzhao Zhang focused their studies on two human breast cancer cell lines that responded to low oxygen by ramping up production of the protein ALKBH5, which removes methyl groups from mRNAs.

Using data from a previously published, multi-center study funded by the National Cancer Institute, researchers aimed to identify the possible benefits of assigning patient navigators to women recently diagnosed with breast cCancer Institute, researchers aimed to identify the possible benefits of assigning patient navigators to women recently diagnosed with breast cancercancer.

A team led by Mary - Frances O'Connor of the University of California, Los Angeles, studied 23 women — 11 of whom suffered from CG — who had lost a mother or sister to breast cancer in the past five years.

The groundbreaking study identified a protein, known as cadherin - 22, as a potential factor in cancer metastasis, or spread, and showed that hindering it decreased the adhesion and invasion rate of breast and brain cancer cells by up to 90 per cent.

The three Ras genes found in humans — H - Ras, K - Ras and N - Ras — were among the first to be linked to cancer development, and a new study led by VCU Massey Cancer Center researcher Paul Dent, Ph.D., has shown the recently approved breast cancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected prcancer development, and a new study led by VCU Massey Cancer Center researcher Paul Dent, Ph.D., has shown the recently approved breast cancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected prCancer Center researcher Paul Dent, Ph.D., has shown the recently approved breast cancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected prcancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected process.

Produced by the UK Small Area Health Statistics Unit (SAHSU), part of the MRC - PHE Centre for Environment & Health based at Imperial College London, the open - access atlas allows researchers, policy makers and members of the public to study the geographical pattern of 14 diseases and conditions such as lung cancer, breast cancer, heart disease, leukemia and low birth weight.

«By understanding how stress accelerates invasion in aggressive breast tumor cells, this work will inform future studies into whether beta - blockers could be a useful adjuvant therapy in the treatment of some aggressive breast cancers.»

Led by researchers at Boston University School of Medicine (BUSM), the study appears online in Breast Cancer Research.

The study, which will be published December 21 in the Journal of Cell Biology, suggests that the loss of these particular Numb proteins makes breast cancers more aggressive and resistant to chemotherapy, but points the way toward new therapeutic approaches that could improve patient outcome by preserving p53 levels.

A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases.

The team has studied the most common kind of breast tumour — estrogen - positive (ER +) and accounting for 80 % of breast cancer tumour cases — that is characterised by a long period of latency with no symptoms.

The findings of the randomized study (S6 - 03) were presented at the 2014 San Antonio Breast Cancer Symposium, held Dec. 6 - 9, by Dr. Kerin Adelson, assistant professor of medical oncology at Yale Cancer Center and chief quality officer at Smilow Cancer Hospital at Yale - New Haven.

For the current study, scientists led by Helmneh Sineshaw, M.D., MPH, analyzed data from 260,174 breast cancer cases recorded in the National Cancer Data Base (NCDB), a national hospital - based cancer registry database jointly sponsored by the American College of Surgeons and the American Cancer Socancer cases recorded in the National Cancer Data Base (NCDB), a national hospital - based cancer registry database jointly sponsored by the American College of Surgeons and the American Cancer SoCancer Data Base (NCDB), a national hospital - based cancer registry database jointly sponsored by the American College of Surgeons and the American Cancer Socancer registry database jointly sponsored by the American College of Surgeons and the American Cancer SoCancer Society.

Should the results be confirmed by further studies, it is possible that patients with certain genetic changes in BRCA1 could be identified as being at higher risk of breast and ovarian cancer.

«Brain metastases are a secondary brain tumour, which means they are caused by cancer cells that escape from primary tumours like lung, breast or melanoma, and travel to the brain,» said Mohini Singh, the study's primary author and a PhD candidate in biochemistry at the Michael G. DeGroote School of Medicine at McMaster.

Researchers conducted an analysis that included nearly 10,000 women with the BRCA1 or BRCA2 genetic mutations to estimate the age - specific risk of breast or ovarian cancer for women with these mutations, according to a study published by JAMA.

The study follows similar investigations by Garland and colleagues of other cancers, including breast, colon, pancreas, bladder and multiple myeloma.

Several authors of this study are supported by the Breast Cancer Research Foundation.

The largest (Hellquist et al) and longest running (Tabár et al) breast cancer screening studies in history reconfirm that regular screening cut breast cancer deaths by roughly a third in all women ages 40 - and - over — including those 40 - 49 — and disprove the lower USPSTF estimates.

In this study, the researchers tested the effects of Olaparib on the tumors formed by human breast cancer cells injected into mice.